Shares in drug companies such as Eli Lilly dropped from their session highs Tuesday afternoon after President Donald Trump said U.S. tariffs on imported pharmaceuticals could be as high as 200%.

Stock indexes are mixed in midday trading Tuesday, coming off a broad sell-off following the Trump administration’s decision ...

By Jarrett Renshaw (Reuters) -Within hours of taking office in January, President Donald Trump boasted about attracting $3 ...

Sales of anti-obesity drugs like Mounjaro and Wegovy are seeing a jump due to a surge in popularity, Business Standard ...

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

AbbVie ABBV has successfully navigated the loss of exclusivity (LOE) for its flagship drug, Humira, by launching two newer ...

The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...

In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...

Canadian manufacturer Balcan Plastics is looking to double its workforce at the facility. The premier business information ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...